Patrícia Correia

15 September 2025

Tribute to the life and legacy of Professor Jorge Cruz

With profound sadness at the passing of Professor Jorge Cruz, we pay tribute to our colleague and our friend. He will be remembered not only as a surgeon but also for his enduring legacy as a teacher, mentor, and guide. We extend our sincere condolences to his family and friends.

Marta Miranda

Joana Seixas

Mariana Ribeiro

Pedro Brito

Diving Into the Immune System Using Single-Cell Genomics

Host

Cristina João, MD, PhD, Myeloma Lymphoma Research Group


Venue

Seminar room

30 September 2025

7th International Kidney and Monoclonal Gammopathies Meeting held at Champalimaud Foundation

The meeting brought together over 200 specialists from 25 countries, representing a truly international effort to advance research and clinical practice in the field of kidney diseases associated with monoclonal gammopathies.

The scientific programme featured a rich series of sessions addressing key areas in the field, including new pathophysiological insights into monoclonal gammopathies and kidney disease, innovations in diagnostic tools and biomarkers, emerging therapeutic strategies, and the latest updates from ongoing clinical trials.

25 September 2025

Molecular Tools Workshop: Empowering the Next Generation of Molecular Biologists

Blending in-depth lectures with guided laboratory sessions, the workshop offered a dynamic introduction to core molecular biology techniques. Participants engaged directly with methods such as RNA extraction, cDNA synthesis, PCR, restriction enzyme digestion, electrophoresis, plasmid DNA isolation, sequence analysis, and experimental design for cloning projects.

By combining expert instruction with hands-on practice, the programme not only reinforced fundamental concepts but also fostered confidence in applying these tools to real-world research challenges.

24 Sep. 2025

Clinical Laboratory Technician

Research
Application Starts: 24 Sep. 2025

The Cell Centre is looking to expand efforts in the GMP production of cell products with a specific focus on immune-monitoring. 

The successful applicant is expected to be pivotal co-worker in the development and improvement of immune cell-based therapies for malignant diseases and the preparation of GMP compliant production of cellular products including gene-modified immune cells and monitoring of anti-cancer directed vaccination.

Subscribe to Cancer
Loading
Please wait...